Pleco Therapeutics
Pleco Therapeutics' aim is to establish the market value and therapeutic potential of our patented PlecoidTM medications by focusing first on orphan cancer treatments. Current pre-clinical development activities at the firm are focused on the development of medicines for Acute Myeloid Leukaemia (AML), a relatively rare blood cancer, and Small-Cell Lung Cancer (SCLC), an aggressive subtype of lung cancer. Both diseases carry a poor prognosis.
Domain
plecotherapeutics.com
Country
ThailandIndustry
Clinical TrialsEmployees
11-50
Last Funding
$17.2M
Founded
2017
Tech Stack (15 technologies)
Frequently Asked Questions
What technologies does Pleco Therapeutics use?+
Pleco Therapeutics uses 15 technologies including Bootstrap, Cookie Control, Modernizr.
What industry is Pleco Therapeutics in?+
Pleco Therapeutics operates in the Clinical Trials industry.
Where is Pleco Therapeutics based?+
Pleco Therapeutics is headquartered in Thailand.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026